eAudiology
Developing Therapies to Prevent Drug-induced Hearing Loss: From Laboratory to Clinic and Back Again (.1 CEUs)
Recorded On: 07/29/2015
-
Register
- Non-member - $60
- Member - $35
- Student - $10
Developing Therapies to Prevent Drug-induced Hearing Loss: From Laboratory to Clinic and Back Again
Recorded July 29, 2015
Duration: 1 hour
Presenter: Lisa L. Cunningham, PhD
CEUs: .1
Who Should Attend: Audiologists interested in ototoxicity and updates on research aimed at preventing hearing loss caused by ototoxic drugs
Instructional Level: Introductory/Intermediate
Program Focus: Knowledge
Learner Outcomes: Upon completion, each participant in the eAudiology Web seminar will be able to:
1. Describe the clinical problem of hearing loss caused by ototoxic drugs
2. Describe a variety of approaches to protecting the inner ear against drug-induced ototoxicity (“otoprotection")
3. List important considerations in the development of co-therapies aimed at preventing drug-induced hearing loss
Description: Thousands of people have permanent hearing loss caused by exposure to lifesaving drugs with ototoxic side effects.Despite decades of research on ototoxicity, no widely-used otoprotective therapy is currently in clinical use.This eAudiology Web seminar will serve as an update on the current status of research aimed at developing protective co-therapies that prevent hearing loss in patients receiving ototoxic drugs.